Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Failure of remyelination of multiple sclerosis (MS) lesions contributes to neurodegeneration that correlates with chronic disability in patients. Currently, there are no available treatments to reduce neurodegeneration, but one therapeutic approach to fill this unmet need is to promote remyelination. As many demyelinated MS lesions contain plentiful oligodendrocyte precursor cells (OPCs), but no mature myelinating oligodendrocytes, research has previously concentrated on promoting OPC maturation. However, some MS lesions contain few OPCs, and therefore, remyelination failure may also be secondary to OPC recruitment failure. Here, in a series of MS samples, we determined how many lesions contained few OPCs, and correlated this to pathological subtype and expression of the chemotactic molecules Semaphorin (Sema) 3A and 3F. 37 % of MS lesions contained low numbers of OPCs, and these were mostly chronic active lesions, in which cells expressed Sema3A (chemorepellent). To test the hypothesis that differential Sema3 expression in demyelinated lesions alters OPC recruitment and the efficiency of subsequent remyelination, we used a focal myelinotoxic mouse model of demyelination. Adding recombinant (r)Sema3A (chemorepellent) to demyelinated lesions reduced OPC recruitment and remyelination, whereas the addition of rSema3F (chemoattractant), or use of transgenic mice with reduced Sema3A expression increased OPC recruitment and remyelination. We conclude that some MS lesions fail to remyelinate secondary to reduced OPC recruitment, and that chemotactic molecules are involved in the mechanism, providing a new group of drug targets to improve remyelination, with a specific target in the Sema3A receptor neuropilin-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888 · cited 1×
“We previously showed that lentiviral delivery of Sema3F to a demyelinated lesion in a different mouse model improved remyelination [37], giving confidence in these results; an important factor considering the number of drug targets that look promising in initial publications, but which later fail to be repeated by pha…”
BackgroundOligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 1×
“Myelinating oligodendrocytes have been shown to be trophic for axons, providing them with necessary metabolic support [14, 25].”
BackgroundRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 1×
“For remyelination to occur, oligodendrocyte precursor cells (OPCs) must survive, proliferate, migrate to the lesion and differentiate into mature oligodendrocytes forming compact myelin sheaths [12].”
BackgroundGlycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 1×
“Myelinating oligodendrocytes have been shown to be trophic for axons, providing them with necessary metabolic support [14, 25].”
BackgroundPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions
Chang, A., Nishiyama, A., Peterson, J., Prineas, J., & Trapp, B. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06404.2000 · Cited by 712
Neuropilin-1 Conveys Semaphorin and VEGF Signaling during Neural and Cardiovascular Development
Gu, C., Rodriguez, E. R., Reimert, D. V., Shu, T., Fritzsch, B., Richards, L. J., Kolodkin, A. L., & Ginty, D. D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00169-2 · Cited by 712
Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., & Fujisawa, H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80392-x · Cited by 656
Rejuvenation of Regeneration in the Aging Central Nervous System
Ruckh, J. M., Zhao, J.-W., Shadrach, J. L., van Wijngaarden, P., Rao, T. N., Wagers, A. J., & Franklin, R. J. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.11.019 · Cited by 649
Yadav, M., Louvet, C., Davini, D., Gardner, J. M., Martinez-Llordella, M., Bailey-Bucktrout, S., Anthony, B. A., Sverdrup, F. M., Head, R., Kuster, D. J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120822 · Cited by 649 · cited 1×
“The receptor for Sema3A is NP1, which is a transmembrane receptor present on OPCs, but also on macrophage/microglia [28] and T-regulatory cells (Treg) [53, 56].”
BackgroundWeiss, J. M., Bilate, A. M., Gobert, M., Ding, Y., Curotto de Lafaille, M. A., Parkhurst, C. N., Xiong, H., Dolpady, J., Frey, A. B., Ruocco, M. G., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120914 · Cited by 621
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS
Fancy, S. P. J., Baranzini, S. E., Zhao, C., Yuk, D.-I., Irvine, K.-A., Kaing, S., Sanai, N., Franklin, R. J. M., & Rowitch, D. H. (2009) · Genes & Development · doi:10.1101/gad.1806309 · Cited by 618
Semaphorin III is needed for normal patterning and growth of nerves, bones and heart
Behar, O., Golden, J. A., Mashimo, H., Schoen, F. J., & Fishman, M. C. (1996) · Nature · doi:10.1038/383525a0 · Cited by 583
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574
Retinoid X receptor gamma signaling accelerates CNS remyelination
Huang, J. K., Jarjour, A. A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel, W., Kagechika, H., Bauer, J., Zhao, C., Evercooren, A. B.-V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2702 · Cited by 547
Self-citationBlocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.018 · Cited by 532
Disruption of Semaphorin III/D Gene Causes Severe Abnormality in Peripheral Nerve Projection
Taniguchi, M., Yuasa, S., Fujisawa, H., Naruse, I., Saga, S., Mishina, M., & Yagi, T. (1997) · Neuron · doi:10.1016/s0896-6273(00)80368-2 · Cited by 516
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
De Stefano, N., Matthews, P. M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 489
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions
Lucchinetti, C., Brück, W., Parisi, J., Scheithauer, B., Rodriguez, M., & Lassmann, H. (1999) · Brain · doi:10.1093/brain/122.12.2279 · Cited by 464
Kaneko, S., Iwanami, A., Nakamura, M., Kishino, A., Kikuchi, K., Shibata, S., Okano, H. J., Ikegami, T., Moriya, A., Konishi, O., et al. (2006) · Nature Medicine · doi:10.1038/nm1505 · Cited by 405
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385 · cited 1×
“Thus, drug inhibition of the Sema3A pathway may increase microglia/macrophage recruitment to demyelinated lesions, which may add further benefit as microglia/macrophage are essential for remyelination as they clear debris [20] and produce cytokines potentially useful for remyelination [31, 52].”
BackgroundIdentification of a microglia phenotype supportive of remyelination
Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., & Boddeke, H. W. G. M. (2012) · Glia · doi:10.1002/glia.21266 · Cited by 358 · cited 1×
“Thus, drug inhibition of the Sema3A pathway may increase microglia/macrophage recruitment to demyelinated lesions, which may add further benefit as microglia/macrophage are essential for remyelination as they clear debris [20] and produce cytokines potentially useful for remyelination [31, 52].”
BackgroundVooijs, M., Jonkers, J., & Berns, A. (2001) · EMBO reports · doi:10.1093/embo-reports/kve064 · Cited by 352
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination
Fancy, S. P. J., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini, S. E., Bruce, C. C., Otero, J. J., Huang, E. J., Nusse, R., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2855 · Cited by 349 · cited 1×
“1 3 [30], Wnt inhibition [10], axin-2 stabilization [11], loss of cdk2 [2], noggin [42], antibodies antagonizing death receptor-6 [29] and CXCR4 [3].”
BackgroundGiger, R. J., Urquhart, E. R., Gillespie, S. K. H., Levengood, D. V., Ginty, D. D., & Kolodkin, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80625-x · Cited by 349
Woodruff, R. H., Fruttiger, M., Richardson, W. D., & Franklin, R. J. M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.014 · Cited by 335
Remyelination can be extensive in multiple sclerosis despite a long disease course
Patani, R., Balaratnam, M., Vora, A., & Reynolds, R. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00805.x · Cited by 318
Mi, S., Miller, R. H., Tang, W., Lee, X., Hu, B., Wu, W., Zhang, Y., Shields, C. B., Zhang, Y., Miklasz, S., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21581 · Cited by 300 · cited 1×
“1 3 [30], Wnt inhibition [10], axin-2 stabilization [11], loss of cdk2 [2], noggin [42], antibodies antagonizing death receptor-6 [29] and CXCR4 [3].”
BackgroundMultiple Sclerosis: Remyelination in Acute Lesions
Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285
Zachary, I. (2005) · Neurosignals · doi:10.1159/000088637 · Cited by 266
Pathogenesis of tissue injury in MS lesions
Trapp, B. D., Bö, L., Mörk, S., & Chang, A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00081-8 · Cited by 259
Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes
Lau, P., Verrier, J. D., Nielsen, J. A., Johnson, K. R., Notterpek, L., & Hudson, L. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1932-08.2008 · Cited by 252 · cited 1×
“We had previously detected Sema3A mRNA in active MS lesions [54], but now describe little protein expression, and this discrepancy is not unprecedented within the brain, as PMP22 mRNA is expressed in oligodendrocytes, but no PMP22 protein is present [22].”
BackgroundDirectional Guidance of Oligodendroglial Migration by Class 3 Semaphorins and Netrin-1
Spassky, N., de Castro, F., Le Bras, B., Heydon, K., Quéraud-LeSaux, F., Bloch-Gallego, E., Chédotal, A., Zalc, B., & Thomas, J.-L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05992.2002 · Cited by 249
Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
Williams, A., Piaton, G., Aigrot, M.-S., Belhadi, A., Theaudin, M., Petermann, F., Thomas, J.-L., Zalc, B., & Lubetzki, C. (2007) · Brain · doi:10.1093/brain/awm202 · Cited by 227
Self-citationCuring CNS autoimmune disease with myelin‐reactive Foxp3+ Treg
Stephens, L. A., Malpass, K. H., & Anderton, S. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200839073 · Cited by 206
ELECTRON MICROSCOPIC FEATURES OF MULTIPLE SCLEROSIS LESIONS
PÉRIER, O., & GRÉGOIRE, A. (1965) · Brain · doi:10.1093/brain/88.5.937 · Cited by 203
Voß, E. V., Škuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., & Stangel, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.008 · Cited by 202
Piaton, G., Aigrot, M.-S., Williams, A., Moyon, S., Tepavcevic, V., Moutkine, I., Gras, J., Matho, K. S., Schmitt, A., Soellner, H., et al. (2011) · Brain · doi:10.1093/brain/awr022 · Cited by 163
Self-citationGuidance of glial precursor cell migration by secreted cues in the developing optic nerve
Sugimoto, Y., Taniguchi, M., Yagi, T., Akagi, Y., Nojyo, Y., & Tamamaki, N. (2001) · Development · doi:10.1242/dev.128.17.3321 · Cited by 147
Inhibition of CNS Remyelination by the Presence of Semaphorin 3A
Syed, Y. A., Hand, E., Möbius, W., Zhao, C., Hofer, M., Nave, K. A., & Kotter, M. R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4930-10.2011 · Cited by 134 · cited 2×
“This finding is discrepant with the previous finding of inhibition of rat OPC differentiation with rSema3A [46], and Fig.”
BackgroundResultLiang, W., Dennis, M. S., Stawicki, S. S., Chanthery, Y. H., Pan, Q., Chen, Y., Eigenbrot, C. W., Yin, J., Koch, A., Wu, X., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.021 · Cited by 127
Fritzsching, B., Haas, J., König, F. B., Kunz, P., Fritzsching, E., Pöschl, J. M. B., Krammer, P. H., Brück, W., Suri‐Payer, E., & Wildemann, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017988 · Cited by 124
A Novel Role for Sema3A in Neuroprotection from Injury Mediated by Activated Microglia
Majed, H., Chandran, S., Niclou, S. P., Nicholas, R. S., Wilkins, A., Wing, M. G., Rhodes, K. E., Spillantini, M. G., & Compston, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0702-05.2006 · Cited by 102
Axonal Injury or Loss in the Internal Capsule and Motor Impairment in Multiple Sclerosis
Lee, M. A., Blamire, A. M., Pendlebury, S. T., Ho, K.-H., Mills, K. R., Styles, P., Palace, J. A., & Matthews, P. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.65 · Cited by 99
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination
Mi, S., Lee, X., Hu, Y., Ji, B., Shao, Z., Yang, W., Huang, G., Walus, L. R., Rhodes, K. J., Gong, B. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2373 · Cited by 94
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions
Sabo, J. K., Aumann, T. D., Merlo, D., Kilpatrick, T. J., & Cate, H. S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5859-10.2011 · Cited by 93
Turbić, A., Leong, S. Y., & Turnley, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025406 · Cited by 82
Many Major CNS Axon Projections Develop Normally in the Absence of Semaphorin III
Catalano, S. M., Messersmith, E. K., Goodman, C. S., Shatz, C. J., & Chédotal, A. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0687 · Cited by 72
Carbajal, K. S., Miranda, J. L., Tsukamoto, M. R., & Lane, T. E. (2011) · Glia · doi:10.1002/glia.21225 · Cited by 66
Caillava, C., Vandenbosch, R., Jablonska, B., Deboux, C., Spigoni, G., Gallo, V., Malgrange, B., & Evercooren, A. B. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201004146 · Cited by 61
Lee, K. K., De Repentigny, Y., Saulnier, R., Rippstein, P., Macklin, W. B., & Kothary, R. (2006) · Glia · doi:10.1002/glia.20343 · Cited by 59
Omoto, M., Yoshida, S., Miyashita, H., Kawakita, T., Yoshida, K., Kishino, A., Kimura, T., Shibata, S., Tsubota, K., Okano, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047716 · Cited by 48
Gender differences in the histopathology of MS?
Kuhlmann, T., GOLDSCHMIDT, T. J., Antel, J. P., Wegner, C., König, F. B., Metz, I., & Brück, W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.014 · Cited by 38
(2007) · Brain · doi:10.1093/brain/awm031 · Cited by 32
Eickholt, B. J., Morrow, R., Walsh, F. S., & Doherty, P. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0636 · Cited by 29
CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signaling
Vora, P., Pillai, P. P., Mustapha, J., Kowal, C., Shaffer, S. R., Bose, R., Namaka, M., & Frost, E. E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.012 · Cited by 25
Cited by
Altered human oligodendrocyte heterogeneity in multiple sclerosis
Jäkel, S., Agirre, E., Mendanha Falcão, A., van Bruggen, D., Lee, K. W., Knuesel, I., Malhotra, D., ffrench-Constant, C., Williams, A., & Castelo-Branco, G. (2019) · Nature · doi:10.1038/s41586-019-0903-2 · Cited by 854
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
“OPC deficiency in these lesions is linked to Semaphorin 3A that prevents OPC migration into the lesion area [205,228].”
BackgroundOligodendrocyte Development and Plasticity
Bergles, D. E., & Richardson, W. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020453 · Cited by 585
Metadata
- Authors
- Boyd, A., Zhang, H., & Williams, A.
- Venue
- Acta Neuropathologica
- Published
- 2013-04-18
- Volume
- 125
- Issue
- 6
- Pages
- 841-859
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2040085463
- Cited by
- 287
- References
- 57
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.